92 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
global long-range planning and financial assessment of business development and M&A opportunities, and director of finance for emerging markets, global
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
endpoint of a hemoglobin increase of³1.0 g/dL from baseline in at least one assessment during Weeks4-12. All eight patients were treated with 50 mg
8-K
AGIO
Agios Pharmaceuticals Inc
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
the Board’s assessment of the Company’s achievement of its performance goals and Ms. Jones’s achievement of her performance goals. Ms. Jones’s annual
8-K
mo3e43a
12 Jul 22
Agios Appoints Brian Goff as Chief Executive Officer
4:14pm
8-K
jl3i0u z298
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
EX-99.2
fdi0 cm4p
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.1
44w0c
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.1
lymctltf2iiab1ngps8
29 Jan 21
Index to Consolidated Financial Statements
4:08pm
8-K
EX-99.1
5pij0bjd
16 Oct 15
Regulation FD Disclosure
12:00am
S-1
EX-10.12
0cvn719e 0z18gyt4
10 Jun 13
IPO registration
12:00am
8-K
EX-99.1
vrz2iy7k08xx2
8 Dec 14
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12:00am